Michal Laufer-Perl

11PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersMolecular targetsAcoustics and noise control (excl. architectural acoustics)Immunogenetics (incl. genetic immunology)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 06, 2026
The prognostic role of pre-treatment global longitudinal strain in patients treated with Immune Checkpoint Inhibitors.

|Mar 10, 2026
Safety and Efficacy of Sodium Glucose Cotransporter-2 Inhibitors in Patients With Cancer and Diabetes.

Moran Gvili Perelman, Rafael Y Brzezinski, Shmuel Banai

|Sep 03, 2025
Atrial Mechanics in Heart Failure With Preserved Ejection Fraction: Effect of a No-Implant Interatrial Shunt.

Michal Laufer-Perl, Nir Flint, Yaron Arbel

|Jun 28, 2025
The predictive value of serial troponin measurements in patients treated with immune checkpoint inhibitors.

Moran Gvili Perelman, Rafael Y Brzezinski, Barliz Waissengrin

|Jan 20, 2023
High neutrophil-to-lymphocyte ratio as an early sign of cardiotoxicity in breast cancer patients treated with anthracycline.

Ranny Baruch, David Zahler, Lior Zornitzki

|Oct 27, 2022
The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors.

Barliz Waissengein, Bian Abu Ata, Ofer Merimsky

Pageof 2

Frequent Collaborators

2 joint publications

Chen Sherez

2 joint publications

Ofer Havakuk

1 joint publications

Yoav Granot

1 joint publications

Yaron Arbel